Suppr超能文献

急性镰状细胞病疼痛的管理。

Management of Acute Sickle Cell Disease Pain.

机构信息

Children's Healthcare of Atlanta, Atlanta, GA.

Morehouse School of Medicine, Atlanta, GA.

出版信息

Pediatr Rev. 2024 Jan 1;45(1):26-38. doi: 10.1542/pir.2022-005631.

Abstract

Pain is a common complication of sickle cell disease. Sickle cell pain can often be effectively managed by pediatricians in outpatient and hospital settings. Acute pain management should be initiated quickly. Patients need to be evaluated for sickle cell complications and other causes of pain. Nonsteroidal anti-inflammatory drugs and opioids are the mainstay of pain treatment, but additional therapies include hydration, local pain control, muscle relaxants, and nonpharmacologic approaches. Healthy lifestyle habits and good behavioral and mental health are important for preventing and coping with sickle cell disease pain. Disease-modifying therapies, such as hydroxyurea, can help prevent sickle hemoglobin polymerization and acute pain episodes. Because sickle cell disease largely affects people who are racialized minorities in the United States, health-care providers need to be aware of how their own personal biases may affect care of these patients.

摘要

疼痛是镰状细胞病的常见并发症。镰状细胞疼痛通常可以由儿科医生在门诊和医院环境中进行有效管理。应迅速开始急性疼痛管理。需要评估患者镰状细胞并发症和其他疼痛原因。非甾体抗炎药和阿片类药物是疼痛治疗的主要方法,但其他治疗方法包括水化、局部疼痛控制、肌肉松弛剂和非药物方法。健康的生活习惯和良好的行为及心理健康对于预防和应对镰状细胞病疼痛很重要。羟基脲等疾病修正疗法有助于预防镰状血红蛋白聚合和急性疼痛发作。由于镰状细胞病主要影响美国的少数族裔人群,医疗保健提供者需要意识到他们自己的个人偏见可能如何影响对这些患者的护理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验